IP 253 (Ranitidine 150 mg)

Pill imprint IP 253 has been identified as Ranitidine hydrochloride 150 mg.

Ranitidine is used in the treatment of gerd; erosive esophagitis; stomach ulcer; gastric ulcer maintenance treatment; duodenal ulcer (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 150 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for IP 253 (Ranitidine 150 mg)

Ranitidine hydrochloride 150 mg IP 253
Ranitidine hydrochloride 150 mg IP 253
Ranitidine hydrochloride 150 mg IP 253
Ranitidine hydrochloride 150 mg IP 253
Ranitidine hydrochloride
Imprint:
IP 253
Strength:
150 mg
Color:
Orange
Size:
9.00 mm
Shape:
Round
Availability:
Rx and/or OTC
Drug Class:
H2 antagonists
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Amneal Pharmaceuticals
National Drug Code (NDC):
53746-0253
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
65162-0253 Amneal Pharmaceuticals
00904-6080 Major Pharmaceuticals
66267-0188 Nucare Pharmaceuticals Inc (repackager)
68071-1321 Nucare Pharmaceuticals Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web1)